Leaflet TANDEMACT 30mg / 4mg tablets

Product code:
W51752002
Quantity:
28
Indicated for:
type 2 diabetes mellitus
Route of administration:
oral
Substance:
pioglitazone + glimepiride (thiazolidinedione antidiabetic + sulfonylurea antidiabetic)
ATC
A10BD06 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Precautions:

Hypoglycemia

This medicine may lower blood sugar.

Pregnancy warning

Use during pregnancy only on medical advice.

The combination of pioglitazone and glimepiride is used for the treatment of type 2 diabetes, helping to control blood glucose levels. Pioglitazone increases the sensitivity of cells to insulin, while glimepiride stimulates insulin secretion from the pancreas.

The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to combine the treatment with a healthy diet and regular exercise to achieve the best results.

Side effects may include hypoglycemia, weight gain, fluid retention, or, in rare cases, heart failure or allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of this combination.

General data about TANDEMACT 30mg / 4mg

Substance:
pioglitazone + glimepiride
Date of latest medicines list:
01-07-2013
Product code:
W51752002
Concentration:
30mg / 4mg
Pharmaceutical form:
tablets
Quantity:
28
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for pioglitazone + glimepiride

  • 30mg/2mg
  • 30mg/4mg
  • 45mg/4mg